Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

948
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
948
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

3.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.7K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

903
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
903
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

348
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
348
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

981
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
981
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

329
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
329

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inherent tissue homeostasis of the juvenile metaphysis provides a foundation for osteosarcoma development.

Nature communications·2026
Same author

In-Hospital Nighttime Blood Pressure and Heart Failure Hospitalization After Discharge in Chronic Coronary Disease.

American journal of hypertension·2026
Same author

Lower in-hospital nighttime systolic blood pressure is associated with heart failure rehospitalization in heart failure with reduced ejection fraction.

Journal of cardiology·2026
Same author

Lipids Contribute to Heterochromatin Condensation Revealed by Quantitative Raman-Brillouin Microscopy.

JACS Au·2026
Same author

Esophageal Cancer Cells Exhibit Heterogeneity in DNA Double-Strand Break Repair and G2/M Checkpoint Arrest Associated With Cell Viability After Ionizing Radiation.

Advances in radiation oncology·2026
Same author

Comprehensive analysis of DNA repair, morphological remodeling and immune-gene expression in patient-derived biliary tract carcinoma organoids following ionizing radiation.

Medical molecular morphology·2026

Related Experiment Video

Updated: Feb 4, 2026

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
07:49

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach

Published on: July 21, 2023

2.0K

Decrease in exhaled hydrogen as marker of congestive heart failure.

Atsushi Shibata1, Yasuo Sugano1,2, Akito Shimouchi3,4

  • 1Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.

Open Heart
|September 25, 2018
PubMed
Summary

Exhaled hydrogen (H2) levels decrease during sleep in chronic heart failure (CHF) patients, indicating increased hydroxyl radical (·OH) production. This decrease correlates with heart failure severity and mitochondrial changes.

Keywords:
heart failure ▪ Idiopathic dilated cardiomyopathy

More Related Videos

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
04:05

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis

Published on: June 30, 2023

2.9K
A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
07:09

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

Published on: February 18, 2022

2.4K

Related Experiment Videos

Last Updated: Feb 4, 2026

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
07:49

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach

Published on: July 21, 2023

2.0K
Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
04:05

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis

Published on: June 30, 2023

2.9K
A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
07:09

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

Published on: February 18, 2022

2.4K

Area of Science:

  • Biomedical Science
  • Cardiology
  • Oxidative Stress Research

Background:

  • Hydrogen (H2) gas is recognized for its antioxidant properties, specifically its ability to scavenge cytotoxic hydroxyl radicals (·OH).
  • Exhaled H2 levels are theorized to reflect systemic antioxidant activity and ·OH production within the body.

Purpose of the Study:

  • To investigate the change in exhaled H2 concentration during overnight sleep in patients with chronic heart failure (CHF).
  • To determine if this overnight change in H2 (ΔH2) correlates with the severity of heart failure.
  • To explore the association between ΔH2 and mitochondrial morphology in heart failure patients.

Main Methods:

  • Collected exhaled breath from 108 CHF patients and 15 controls to measure H2 concentration using gas chromatography.
  • Calculated the overnight change in H2 concentration (ΔH2) by comparing pre-sleep and morning measurements.
  • Assessed mitochondrial morphology via transmission electron microscopy on endomyocardial biopsies from 18 CHF patients.

Main Results:

  • Patients with CHF exhibited significantly lower overnight ΔH2 compared to controls (-4.3±1.0 vs 2.0±2.1 ppm, p=0.030).
  • A negative ΔH2 was significantly associated with lower cardiac index (CI), a marker of heart failure severity.
  • ΔH2 showed a negative correlation with mitochondrial vacuolization and cristae remodeling, indicating impaired mitochondrial structure.

Conclusions:

  • A decrease in exhaled H2 during sleep is linked to increased ·OH production and is associated with the severity of chronic heart failure.
  • Overnight ΔH2 shows potential as a non-invasive biomarker for assessing CHF severity and related mitochondrial dysfunction.